These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 16570923

  • 1. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.
    Ye Y, Bloch S, Xu B, Achilefu S.
    J Med Chem; 2006 Apr 06; 49(7):2268-75. PubMed ID: 16570923
    [Abstract] [Full Text] [Related]

  • 2. Novel near-infrared fluorescent integrin-targeted DFO analogue.
    Ye Y, Bloch S, Xu B, Achilefu S.
    Bioconjug Chem; 2008 Jan 06; 19(1):225-34. PubMed ID: 18038965
    [Abstract] [Full Text] [Related]

  • 3. Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging.
    Ye Y, Akers W, Xu B, Bloch S, Odonkor C, Achilefu S.
    Bioorg Med Chem Lett; 2012 Sep 01; 22(17):5405-9. PubMed ID: 22871580
    [Abstract] [Full Text] [Related]

  • 4. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J, Wan S, Tian J, Li S, Deng D, Qian Z, Gu Y.
    Contrast Media Mol Imaging; 2012 Sep 01; 7(4):390-402. PubMed ID: 22649045
    [Abstract] [Full Text] [Related]

  • 5. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X.
    J Nucl Med; 2007 Jul 01; 48(7):1162-71. PubMed ID: 17574975
    [Abstract] [Full Text] [Related]

  • 6. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M, Laufer B, Kessler H, Wester HJ.
    Acc Chem Res; 2009 Jul 21; 42(7):969-80. PubMed ID: 19489579
    [Abstract] [Full Text] [Related]

  • 7. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
    Cheng Z, Wu Y, Xiong Z, Gambhir SS, Chen X.
    Bioconjug Chem; 2005 Jul 21; 16(6):1433-41. PubMed ID: 16287239
    [Abstract] [Full Text] [Related]

  • 8. Targeting Beta-3 integrin using a linear hexapeptide labeled with a near-infrared fluorescent molecular probe.
    Bloch S, Xu B, Ye Y, Liang K, Nikiforovich GV, Achilefu S.
    Mol Pharm; 2006 Jul 21; 3(5):539-49. PubMed ID: 17009853
    [Abstract] [Full Text] [Related]

  • 9. Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.
    Achilefu S, Bloch S, Markiewicz MA, Zhong T, Ye Y, Dorshow RB, Chance B, Liang K.
    Proc Natl Acad Sci U S A; 2005 May 31; 102(22):7976-81. PubMed ID: 15911748
    [Abstract] [Full Text] [Related]

  • 10. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers.
    Wu Y, Cai W, Chen X.
    Mol Imaging Biol; 2006 May 31; 8(4):226-36. PubMed ID: 16791749
    [Abstract] [Full Text] [Related]

  • 11. Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide.
    Edwards WB, Akers WJ, Ye Y, Cheney PP, Bloch S, Xu B, Laforest R, Achilefu S.
    Mol Imaging; 2009 May 31; 8(2):101-10. PubMed ID: 19397855
    [Abstract] [Full Text] [Related]

  • 12. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
    Mathejczyk JE, Pauli J, Dullin C, Napp J, Tietze LF, Kessler H, Resch-Genger U, Alves F.
    Mol Imaging; 2011 Dec 31; 10(6):469-80. PubMed ID: 22201538
    [Abstract] [Full Text] [Related]

  • 13. Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging.
    Ye Y, Xu B, Nikiforovich GV, Bloch S, Achilefu S.
    Bioorg Med Chem Lett; 2011 Apr 01; 21(7):2116-20. PubMed ID: 21349709
    [Abstract] [Full Text] [Related]

  • 14. Comparison of near-infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo.
    Guo J, Du C, Shan L, Zhu H, Xue B, Qian Z, Achilefu S, Gu Y.
    Contrast Media Mol Imaging; 2012 Apr 01; 7(3):289-301. PubMed ID: 22539399
    [Abstract] [Full Text] [Related]

  • 15. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
    Chen X, Conti PS, Moats RA.
    Cancer Res; 2004 Nov 01; 64(21):8009-14. PubMed ID: 15520209
    [Abstract] [Full Text] [Related]

  • 16. A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts.
    Lanzardo S, Conti L, Brioschi C, Bartolomeo MP, Arosio D, Belvisi L, Manzoni L, Maiocchi A, Maisano F, Forni G.
    Contrast Media Mol Imaging; 2011 Nov 01; 6(6):449-58. PubMed ID: 22144022
    [Abstract] [Full Text] [Related]

  • 17. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct 01; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 18. Multivalent carbocyanine molecular probes: synthesis and applications.
    Ye Y, Bloch S, Kao J, Achilefu S.
    Bioconjug Chem; 2005 Oct 01; 16(1):51-61. PubMed ID: 15656575
    [Abstract] [Full Text] [Related]

  • 19. Dual-functional protein for one-step production of a soluble and targeted fluorescent dye.
    Xiao Y, Zhang Q, Wang Y, Wang B, Sun F, Han Z, Feng Y, Yang H, Meng S, Wang Z.
    Theranostics; 2018 Oct 01; 8(11):3111-3125. PubMed ID: 29896306
    [Abstract] [Full Text] [Related]

  • 20. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.
    Buckle T, van Willigen DM, Spa SJ, Hensbergen AW, van der Wal S, de Korne CM, Welling MM, van der Poel HG, Hardwick JCH, van Leeuwen FWB.
    J Nucl Med; 2018 Jun 01; 59(6):986-992. PubMed ID: 29449447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.